Deubiquitinases at the interplay between hematopoietic stem cell aging and myelodysplastic transformation

Hematopoietic stem cells (HSC) maintain blood production throughout life. Nevertheless, HSC functionality deteriorates upon physiological aging leading to the increased prevalence of haematological diseases and hematopoietic malignancies in the elderly. Deubiquitinating enzymes (DUBs) by reverting p...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:FEBS letters Ročník 598; číslo 22; s. 2807 - 2808
Hlavní autoři: Citterio, Elisabetta, Ronchi, Antonella Ellena
Médium: Journal Article
Jazyk:angličtina
Vydáno: England John Wiley and Sons Inc 01.11.2024
Témata:
ISSN:0014-5793, 1873-3468, 1873-3468
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Hematopoietic stem cells (HSC) maintain blood production throughout life. Nevertheless, HSC functionality deteriorates upon physiological aging leading to the increased prevalence of haematological diseases and hematopoietic malignancies in the elderly. Deubiquitinating enzymes (DUBs) by reverting protein ubiquitination ensure proper proteostasis, a key process in HSC maintenance and fitness. Hematopoietic stem cell (HSC) function declines during aging, leading to a higher risk of hematopoietic malignancies. By reverting protein ubiquitination, deubiquitinating enzymes (DUBs) ensure protein homeostasis, a key process in HSC maintenance. Here, we discuss how alterations in DUBs function exacerbate HSC aging, predisposing them to myelodysplastic syndrome and leukaemia. The potential of DUBs as therapeutic targets is highlighted.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:0014-5793
1873-3468
1873-3468
DOI:10.1002/1873-3468.14991